An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Effectiveness of Avamys Administered in Korean Patients According to the Prescribing Information.
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2014
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 26 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2014 Planned End Date changed from 1 May 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 11 May 2012 Official Title amended as reported by ClinicalTrials.gov.